IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 95

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Review on design synthesis of new Benzimidazole and Benzothiozole fused ring derivatives for anti cancer an anti microbial activity
Authors Name: Junaid Tantray , Akhilesh Patel , Sourabh Kosey , Ramesh Kumar , Mohd Zaid
Download E-Certificate: Download
Author Reg. ID:
IJNRD_184190
Published Paper Id: IJNRD2211248
Published In: Volume 7 Issue 11, November-2022
DOI:
Abstract: Over the course of more than a century, researchers have researched the characteristics of benzimidazole and its derivatives. Substitutes and intermediates for the synthesis of compounds with potential as pharmacological or biological agents include benzimidazole derivatives. Antiulcer, anticancer, and anthelmintic species are just a few of the therapeutic areas where substituted benzimidazole derivatives have found use. This article provides a systematic assessment of recent advancements in benzimidazole-based molecules across the entire spectrum of medicinal chemistry as anticancer agents.In order to assist medicinal chemists in creating an SAR on benzimidazole drugs/compounds, this review will be further helpful for the researcher based on substitution pattern around the nucleus.A bicyclic molecule of the heterocyclic class is benzothiazole (BTA). BTA derivatives have a wide range of biological effects, including those against cancer, inflammation, tumours, viruses, bacteria, proliferative cells, diabetes, convulsions, tuberculosis, leishmaniasis, histamine, and fungi, among others. The metalloenzyme carbonic anhydrase was significantly inhibited by the BTA scaffolds (CA). In this review, a thorough literature assessment over the previous 10 years reveals that BTA derivatives are primarily used as anticancer medicines. These substances work against different cancer cell lines by a variety of methods, some of which have not been well researched or understood. On the other hand, more research has been done on how BTA derivatives might block tumour-associated CAs, and these substances may be used as anticancer leads for the developmentof treatments for tumours that are under-oxygenated
Keywords: Benzimidazole, synthesis, pharmacological activity, antitubercular, anticancer, Benzothiazole; anticancer agent; drug targets; scaffold; carbonic anhydrase inhibitor
Cite Article: "Review on design synthesis of new Benzimidazole and Benzothiozole fused ring derivatives for anti cancer an anti microbial activity", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 11, page no.c373-c388, November-2022, Available :http://www.ijnrd.org/papers/IJNRD2211248.pdf
Downloads: 000118747
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2211248
Registration ID: 184190
Published In: Volume 7 Issue 11, November-2022
DOI (Digital Object Identifier):
Page No: c373-c388
Country: Jaipur, Jaipur, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2211248
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2211248
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD